11-Feb-2020 | Facts and Factors
Facts and Factors have authored “Ophthalmic Drugs Market By Drug Class (Antiallergy, Anti-VEGF Agents, Anti-Inflammatory, Antiglaucoma, & Others), By Disease (Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Retinal Disorders, Uveitis, & Others), By Dosage (Gels, Eye Solutions, Capsules & Tablets, Eye Drops, & Ointments), By Route of Administration (Topical, Local Ocular, & Systematic), By Product (Prescription Drugs & OTC), And By Regions - Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2021 - 2026”. Based on our analysis, the global ophthalmic drugs market in 2020 is over USD 37.4 Billion and is expected to reach around USD 62.9 Billion by 2026. The anticipated CAGR for the global ophthalmic drugs market is around 5.9% from 2021 to 2026.
Ophthalmic drugs, also referred to as eye medications, are solid, liquid, or semi-solid formulations that are intended to apply to the eyelids and conjunctiva. The drugs are certain emulsions, ointments, and/or active pharmaceutical ingredient(s).
Browse the full “Ophthalmic Drugs Market By Drug Class (Antiallergy, Anti-VEGF Agents, Anti-Inflammatory, Antiglaucoma, & Others), By Disease (Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Retinal Disorders, Uveitis, & Others), By Dosage (Gels, Eye Solutions, Capsules & Tablets, Eye Drops, & Ointments), By Route of Administration (Topical, Local Ocular, & Systematic), By Product (Prescription Drugs & OTC), And By Regions - Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2021 - 2026" report at https://www.fnfresearch.com/ophthalmic-drugs-market-report
High prevalence of ocular disease cases likely to bolster the ophthalmic drug market
The visual impairment incidences have been surging considerably worldwide irrespective of the age group. This challenging situation has urged drug manufacturers and pharmaceutical companies to design and supply effective medications against this rapidly spreading disorder. Hence, the introduction of novel effective ophthalmic drugs bolsters the global ophthalmic drug market. Exposure to air and water pollution poses a greater risk to the eyes. Thus, surging the demand for the drugs and propelling the global ophthalmic drug market.
Ophthalmic drugs-associated side effects expected to hamper the ophthalmic market
Eye treatment involves a risky operation and has various side effects. In some cases, ophthalmic drugs fail to maintain the intraocular pressure of the eye while treatment. In most cases, the medicine may cause internal burning in the eye and/or temporary blurred vision. Owing to these attributes, the ophthalmic drugs market enters a declining phase.
Anti-infective drug class leads the global ophthalmic drug market
The anti-infective drug category, from the past few years, has been holding the dominating position in the global ophthalmic market. In 2019, the category accounts for more than one-third of the market share in terms of revenue. However, the anti-glaucoma drugs are projected to augment at a relatively faster CAGR throughout the forecast period.
Over-the-counter drug type accounts for higher sales and revenue share
Based on the type segment, ophthalmic drugs are categorized into prescription drugs and over-the-counter drugs. Among both, over-the-counter drug type holds around two-third share in the overall sales and revenue. However, the prescription drug category is anticipated to grow at higher CAGR between 2020 and 2026.
Retail pharmacies expect better sales and revenue share during the forecast period
Despite the consecutive decline in volume sales, the revenue generated by retail pharmacies is thrusting at a considerable rate. Based on the forecast, the drug category is likely to follow the same revenue growth trend. However, the hospital pharmacies category holds the leading position in the global market revenue generation.
Key market players
The key market participants for the global ophthalmic drugs market are Alcon, Johnson & Johnson Services Inc., Bausch Health, Allergan, Pfizer, Inc., Bayer AG, Santen Pharmaceutical Co. Ltd., Genetech, Inc., Novartis AG, Regeneron, Merck & Co., Coherus Biosciences Inc., AbbVie Inc., F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., and Sun Pharmaceutical Industries Ltd., among others.
The global ophthalmic drugs market is segmented as:
Global Ophthalmic Drugs Market: By Drug Class Segment Analysis
- Antiallergy
- Anti-VEGF Agents
- Anti-Inflammatory
- Nonsteroidal Drugs
- Steroidal Drugs
- Antiglaucoma
- Others
Global Ophthalmic Drugs Market: By Disease Segment Analysis
- Dry Eye
- Eye Allergy
- Glaucoma
- Eye Infection
- Retinal Disorders
- Macular Degeneration
- Diabetic Retinopathy
- Others
- Uveitis
- Others
Global Ophthalmic Drugs Market: By Dosage Segment Analysis
- Gels
- Eye Solutions
- Capsules & Tablets
- Eye Drops
- Ointments
Global Ophthalmic Drugs Market: By Route of Administration Segment Analysis
- Topical
- Local Ocular
- Subconjunctival
- Retrobulbar
- Intracameral
- Systematic
Global Ophthalmic Drugs Market: By Product Segment Analysis
Global Ophthalmic DrugsMarket: Regional Segmentation Analysis
By Region
- North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A - 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
